Factors involved in the T helper type 1 and type 2 cell commitment and osteoclast regulation in inflammatory apical diseases

Oral Microbiology and Immunology

Volumn 24, Issue 1, 2009, Pages 25-31

  Fukada, S Y ^a   Silva, T A ^b   Garlet, G P ^a   Rosa, A L ^a   Da Silva, J S ^a   Cunha, F Q ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Apical periodontitis; Bone resorption; Th1; Th2; Treg cells

Indexed keywords

CELL MARKER; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; INTERLEUKIN 10; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; GRANULOMA; HUMAN; HUMAN TISSUE; INFLAMMATORY APICAL DISEASE; OSTEOCLAST; PERIODONTITIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; TOOTH ROOT;

ADULT; ALVEOLAR BONE LOSS; CHEMOKINE CCL3; CHEMOKINE CXCL12; CHEMOKINES, CC; CHEMOTAXIS; CHRONIC DISEASE; FORKHEAD TRANSCRIPTION FACTORS; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; MIDDLE AGED; OSTEOCLASTS; OSTEOPROTEGERIN; PERIAPICAL GRANULOMA; RADICULAR CYST; RANK LIGAND; RECEPTORS, CCR1; RECEPTORS, CXCR4; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS;

EID: 57649174491     PISSN: 09020055     EISSN: 1399302X     Source Type: Journal    
DOI: 10.1111/j.1399-302X.2008.00469.x     Document Type: Article

References (54)

1. Alayan J, Ivanovski S, Farah CS. Alveolar bone loss in T helper 1/T helper 2 cytokine-deficient mice. J Periodontal Res 2007 : 42 : 97 103.
2. Annunziato F, Cosmi L, Manetti R et al. Reversal of human allergen-specific CRTH2+ T(H)2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide. J Allergy Clin Immunol 2001 : 108 : 815 821.
3. Balto K, Sasaki H, Stashenko P. Interleukin-6 deficiency increases inflammatory bone destruction. Infect Immun 2001 : 69 : 744 750.
4. Bendre MS, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 2003 : 33 : 28 37.
5. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003 : 423 : 337 342.
6. Chen W, Jin W, Hardegen N et al. Conversion of peripheral CD4+ CD25- naive T cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003 : 198 : 1875 1886.
7. Colic M, Lukic A, Vucevic D et al. Correlation between phenotypic characteristics of mononuclear cells isolated from human periapical lesions and their in vitro production of Th1 and Th2 cytokines. Arch Oral Biol 2006 : 51 : 1120 1130.
8. Colic M, Vasilijic S, Gazivoda D, Vucevic D, Marjanovic M, Lukic A. Interleukin-17 plays a role in exacerbation of inflammation within chronic periapical lesions. Eur J Oral Sci 2007 : 115 : 315 320.
9. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005 : 6 : 331 337.
10. Fu S, Zhang N, Yopp AC et al. TGF-beta induces Foxp3+ T-regulatory cells from CD4+ CD25- precursors. Am J Transplant 2004 : 4 : 1614 1627.
11. Grassi F, Cristino S, Toneguzzi S, Piacentini A, Facchini A, Lisignoli G. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J Cell Physiol 2004 : 199 : 244 251.
12. Jankovic D, Liu Z, Gause WC. Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol 2001 : 22 : 450 457.
13. Kabashima H, Nagata K, Maeda K, Iijima T. Presence of IFN-gamma and IL-4 in human periapical granulation tissues and regeneration tissues. Cytokine 2001 : 14 : 289 293.
14. Kawashima N, Stashenko P. Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation. Arch Oral Biol 1999 : 44 : 55 66.
15. Kawashima N, Suzuki N, Yang G et al. Kinetics of RANKL, RANK and OPG expressions in experimentally induced rat periapical lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 : 103 : 707 711.
16. Kimura T, Ishii Y, Yoh K et al. Overexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis. Am J Pathol 2006 : 169 : 96 104.
17. Kong YY, Yoshida H, Sarosi I et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999 : 397 : 315 323.
18. Kotake S, Udagawa N, Takahashi N et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999 : 103 : 1345 1352.
19. Lacey DL, Timms E, Tan HL et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998 : 93 : 165 176.
20. Leiden JM. Transcriptional regulation of T cell receptor genes. Annu Rev Immunol 1993 : 11 : 539 570.
21. Lighvani AA, Frucht DM, Jankovic D et al. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci U S A 2001 : 98 : 15137 15142.
22. Loser K, Mehling A, Loeser S et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 2006 : 12 : 1372 1379.
23. Maruyama K, Takada Y, Ray N et al. Receptor activator of NF-kappa B ligand and osteoprotegerin regulate proinflammatory cytokine production in mice. J Immunol 2006 : 177 : 3799 3805.
24. Menezes R, Garlet TP, Letra A et al. Differential patterns of receptor activator of nuclear factor kappa B ligand/osteoprotegerin expression in human periapical granulomas: possible association with progressive or stable nature of the lesions. J Endod 2008 : 34 : 932 938.
25. Menezes R, Bramante CM, da Silva Paiva KB et al. Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 : 102 : 404 409.
26. Merika M, Orkin SH. DNA-binding specificity of GATA family transcription factors. Mol Cell Biol 1993 : 13 : 3999 4010.
27. Nair PN. Pathogenesis of apical periodontitis and the causes of endodontic failures. Crit Rev Oral Biol Med 2004 : 15 : 348 381.
28. Romagnani S. Regulation of the T cell response. Clin Exp Allergy 2006 : 36 : 1357 1366.
29. Roncador G, Brown PJ, Maestre L et al. Analysis of FOXP3 protein expression in human CD4+ CD25+ regulatory T cells at the single-cell level. Eur J Immunol 2005 : 35 : 1681 1691.
30. Sabeti M, Simon J, Kermani V, Valles Y, Rostein I. Detection of receptor activator of NF-kappa beta ligand in apical periodontitis. J Endod 2005 : 31 : 17 18.
31. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004 : 22 : 531 562.
32. Sasaki H, Balto K, Kawashima N et al. Gamma interferon (IFN-gamma) and IFN-gamma-inducing cytokines interleukin-12 (IL-12) and IL-18 do not augment infection-stimulated bone resorption in vivo. Clin Diagn Lab Immunol 2004 : 11 : 106 110.
33. Sasaki H, Hou L, Belani A et al. IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo. J Immunol 2000 : 165 : 3626 3630.
34. Sato K, Suematsu A, Okamoto K et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006 : 203 : 2673 2682.
35. Schneeweis LA, Willard D, Milla ME. Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-kappaB ligand. J Biol Chem 2005 : 280 : 41155 41164.
36. Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ. Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 2007 : 86 : 306 319.
37. Silva TA, Garlet GP, Lara VS, Martins W Jr., Silva JS, Cunha FQ. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases. Oral Microbiol Immunol 2005 : 20 : 310 316.
38. Skapenko A, Niedobitek GU, Kalden JR, Lipsky PE, Schulze-Koops H. Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10. J Immunol 2004 : 172 : 6427 6434.
39. Stashenko P, Teles R, D'Souza R. Periapical inflammatory responses and their modulation. Crit Rev Oral Biol Med 1998 : 9 : 498 521.
40. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000 : 100 : 655 669.
41. Taubman MA, Valverde P, Han X, Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 2005 : 76 : 2033 2041.
42. Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 2002 : 20 : 795 823.
43. Vernal R, Chaparro A, Graumann R, Puente J, Valenzuela MA, Gamonal J. Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients. J Periodontol 2004 : 75 : 1586 1591.
44. Vernal R, Dezerega A, Dutzan N et al. RANKL in human periapical granuloma: possible involvement in periapical bone destruction. Oral Dis 2006 : 12 : 283 289.
45. Vernal R, Dutzan N, Chaparro A et al. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol 2005 : 32 : 383 389.
46. Votta BJ, White JR, Dodds RA et al. CKbeta-8 [CCL23], a novel CC chemokine, is chemotactic for human osteoclast precursors and is expressed in bone tissues. J Cell Physiol 2000 : 183 : 196 207.
47. Wang CY, Stashenko P. Kinetics of bone-resorbing activity in developing periapical lesions. J Dent Res 1991 : 70 : 1362 1366.
48. Wong BR, Rho J, Arron J et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 1997 : 272 : 25190 25194.
49. Yamazaki S, Iyoda T, Tarbell K et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003 : 198 : 235 247.
50. Yang M, Mailhot G, MacKay CA, Mason-Savas A, Aubin J, Odgren PR. Chemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1gamma) in osteoclastogenesis in vivo and in vitro. Blood 2006 : 107 : 2262 2270.
51. Yasuda H, Shima N, Nakagawa N et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998 : 95 : 3597 3602.
52. Yu X, Huang Y, Collin-Osdoby P, Osdoby P. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res 2004 : 19 : 2065 2077.
53. Zhang X, Teng YT. Interleukin-10 inhibits gram-negative-microbe-specific human receptor activator of NF-kappaB ligand-positive CD4+ Th1-cell-associated alveolar bone loss in vivo. Infect Immun 2006 : 74 : 4927 4931.
54. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997 : 89 : 587 596.